Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

By Lundqvist Andreas   Palmborg Andreas   Bidla Gawa   Whelan Mike   Pandha Hardev   Pisa Pavel  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 155-165

Humana Press, Inc

Access to resources Recommend Favorite

The `peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity

By Graner Michael W.  

International Journal of Hyperthermia, Vol. 29, Iss. 5, 2013-08 ,pp. : 380-389

Informa Healthcare

Access to resources Recommend Favorite

Radicicol potentiates heat-induced cell killing in a human oesophageal cancer cell line: the Hsp90 chaperone complex as a new molecular target for enhancement of thermosensitivity

By Akimoto T.   Nonaka T.   Harashima K.   Sakurai H.   Ishikawa H.   Mitsuhashi N.  

International Journal of Radiation Biology, Vol. 80, Iss. 7, 2004-07 ,pp. : 483-492

Informa Healthcare

Access to resources Recommend Favorite

Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 178-186

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2639-2646

Spandidos Publications

Access to resources Recommend Favorite